Deakin University researchers have joined scientists from SeaGen Aquaculture and Gippsland-based biotech company Offshore Biotechnologies to undertake ...

Choose from Biotechnology Background stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

Scientists have developed a solution that could transform the way we image patients and objects ... scientists aimed to minimise the background noise generated by the device.

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take a drubbing. But at OSE Immunotherapeutics, which aims to prevent ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

“There is no established scientific evidence to prove any potential harm of GM crops to health and to environment,” says Dafang Huang, former director of the Institute of Biotechnology under CAA ...

Startup Biosphere’s technology demonstrates the potential of UV sterilization for biomanufacturing, allowing biotech companies ... “How do you distribute the light to all of the different ...

Imperative Care has received a green light from the FDA for its large-bore catheter to help remove stroke-causing blood clots from within the brain. The new 510(k) clearance expands the portfolio ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) candidate from a clinical hold. When Amylyx had asked the FDA to ...